Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Indaptus Therapeutics (NASDAQ:INDP) reported its Q4 earnings results on Wednesday, March 13, 2024 at 07:30 AM.
Here's what investors need to know about the announcement.
Indaptus Therapeutics beat estimated earnings by 15.0%, reporting an EPS of $-0.46 versus an estimate of $-0.54.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $0.08 which was followed by a 10.0% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Indaptus Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: INDP